Prevention of Coronary Disease in Women

Wenger NK . Coronary disease in women. Ann Rev Med 1985, 36: 285–294.

Eaker ED Packard B Wenger NK Clarkson TB Tyroler HA . Coronary artery disease in women. Am J Cardiol 1988, 61: 641–644.

Castelli WP . Cardiovascular disease in women. Am J Obstet Gynecol 1988; 158: 1553–1560.

Wenger NK . Coronary heart disease in women: a ‘new’ problem. Hospital Practice 1992; 27: 59–74.

Medical Research Council Working Party. MRC Trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97–104.

Willett WC Green A Stampfer MJ Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303–1309.

Isles CG Hole DJ Hawthorne VM Lever AF . Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley Survey: comparison with men. Lancet 1992; 339: 702–706.

Jacobs D Blackburn H Higgins M. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046–1060.

Hulley SB Walsh JMB Newman TB . Health Policy on blood cholesterol. Time to change direction. Circulation 1992; 86: 1026–1029.

Kannel WB Brand FN . Cardiovascular risk factors in the elderly. In: Andres R Bierman EL Hazzard WR . (Eds). Principles of geriatric medicine. New York, McGraw-Hill 1985, page 109.

Godsland IF Wynn V Crook D Miller NE . Sex, plasma lipoproteins and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467–1502.

Crouse JR . Gender, lipoproteins, diet and cardiovascular risk. Lancet 1989; 1: 318–320.

Kannel WB . Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114: 413–419.

Ramsay LE Yeo WW Jackson PR . Dietary reduction of serum cholesterol concentration: time to think again. Br Med J 1991; 303: 953–957.

Mata P Garrido JA Ordovas JM Effect of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 1992; 56: 77–83.

Lerner DJ Kannel WB . Patterns of coronary heart disease morbidity and mortality in the sexes: A twenty-six year follow-up of the Framingham population. Am Heart J 1986; 111: 383–390.

Barrett-Connor EL Cohn BA Wingard DL Edelstein SL . Why is diabetes mellitus a stronger risk factor for fatal ischaemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265: 627–631.

Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Br Med J 1991; 303: 893–896.

Ornish D Brown SE Scherwitz LW Can lifestyle changes reverse coronary heart disease? Lancet 1990; 336: 129–133.

Kane JP Malloy MJ Ports TA Phillips NR Diehl JC Havel RJ . Regression of coronary atherosclerosis during treatment of familial hypercholesterolaemia with combined drug regimens. JAMA 1990; 264: 3007–3012.

Brensike JF Levy RI Kelsey SF Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II coronary prevention study. Circulation 1984; 69: 313–324.

Buchwald H Campos CT Matts JP Women in the POSCH Trial: effects of aggressive cholesterol modification in women with coronary heart disease. Ann Surg 1992; 216: 389–400.

Manson JE Colditz GA Stampfer MJ A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882–889.

National Institutes of Health Concensus Development Panel. Health implications of obesity: National Institutes of Health Concensus Development Conference Statement. Ann Intern Med 1985; 103: 147–151.

Despres J-P. Assessing obesity: Beyond BMI. National Institute of Nutrition Review No 19. National Institute of Nutrition, Ottawa, 1992.

Despres J-P Moorjani S Lupien PJ Tremblay A Nadeau A Bouchard C. Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Arteriosclerosis 1990; 10: 497–511.

Seidell JC Cigolini M Charzewska J Fat distribution and gender differences in serum lipids in men and women from four European communities. Atherosclerosis 1991; 87: 203–210.

Larsson B Bengtsson C Bjorntorp P Is abdominal fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? Am J Epidemiol 1992; 135: 266–273.

Lee I-M Paffenbarger RS . Change in body weight and longevity. JAMA 1992; 268: 2045–2049.

Lissner L Odell PM D'Agostino RB Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991; 324: 1839–1844.

MORI. The psychology of food survey 1992.

Jick H Dinan B Herman R Rothman KJ . Myocardial infarction and other vascular diseases in young women. Role of oestrogens and other factors. JAMA 1978; 240: 2548–2552.

Croft P Hannaford PC . Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners oral contraception study. Br Med J 1989, 298: 165–168.

Stampfer MJ Willett WC Colditz GA Speizer FE Hennekens CH . A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988, 319: 1313–1317.

Ginsburg J. The menopause, hormone replacement therapy and cardiovascular disease. In: Burger H Boulet M , eds. A portrait of the menopause: expert reports on medical and therapeutic strategies for the 1990's. Parthenon Publishing, Carnforth 1991.

Stampfer MJ Colditz GA Willett WC Post-menopausal oestrogen therapy and cardiovascular disease: ten year follow-up from the Nurses Health Study. N Engl J Med 1991; 325: 756–762.

Bush TL Barrett-Connor E Cowan LD Cardiovascular mortality and non-contraceptive use of oestrogen in women: results from the Lipid Research Clinic Program Follow-Up Study. Circulation 1987; 75: 1102–1109.

Henderson BE Paganini-Hill A Ross RK . Decreased mortality in users of estrogen replacement therapy. Arch Int Med 1991; 151: 75–78.

Sullivan JM Zwaag RV Hughes JP Oestrogen replacement and coronary artery disease: The effect on survival in post-menopausal women. Arch Intem Med 1990; 150: 2557–2562.

Gruchow HW Anderson AJ Barboriak JJ Sobocinski KA Post menopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115: 954–963.

McFarland KF Boniface ME Homung CA Earnhardt W Humphries JO . Risk factors and non contraceptive oestrogen use in women with and without coronary disease.

Falkeborn M Persson I Adami H-O The risk of acute myocardial infarction after oestrogen and oestrogen-progestagen replacement. Br J Obstet Gynaecol 1992; 99: 821–828.

Barrett-Connor E Wingard DL Criqui MH . Post-menopausal oestrogen use and heart disease risk factors in the 1980's. JAMA 1989; 261: 2095–2100.

Matthews KA Meilahn E Kuller LH Kelsey SF Cagguila AW Wing PR . Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–646.

Lobo RA . Cardiovascular implications of estrogen replacement therapy. Obstet Gynaecol 1990; 75: 18S–25S.

Bush TL . Extra skeletal effects of estrogen and the prevention of atherosclerosis. Osteoporosis International 1991; 2: 5–11.

Jacobs HS Loeffler FE . Post menopausal hormone replacement therapy. BMJ 1992; 305: 1403–1408.